Neutral sphingomyelinase 2: A promising drug target for CNS disease
2024 · Advances in pharmacology · 4 citations
https://doi.org/10.1016/bs.apha.2024.10.015
J
Jason Zavras
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Jason Zavras is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat